• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过光学相干断层扫描评估葡萄膜炎性黄斑水肿的临床有意义的变化阈值。

Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.

机构信息

Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland 21205, USA.

出版信息

Am J Ophthalmol. 2011 Dec;152(6):1044-1052.e5. doi: 10.1016/j.ajo.2011.05.028. Epub 2011 Sep 8.

DOI:10.1016/j.ajo.2011.05.028
PMID:21861971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3223264/
Abstract

PURPOSE

To identify a clinically meaningful threshold for change in retinal thickness measured by optical coherence tomography for patients with uveitic macular edema using correlation with change in visual acuity.

DESIGN

Cross-sectional and longitudinal study.

METHODS

One hundred twenty-eight eyes (101 individuals) with macular edema enrolled in the Multicenter Uveitis Steroid Treatment (MUST) trial. At enrollment and after 6 months of follow-up, retinal thickness was measured at the central subfield with time-domain optical coherence tomography and visual acuity was measured with logarithmic (Early Treatment Diabetic Retinopathy Study) visual acuity charts. Participants were classified as having macular edema if the retinal thickness was 260 μm or more.

RESULTS

A threshold for change in retinal center subfield thickness of 20% balanced the percentage of false positives and false negatives for predicting more than a 10-letter change in visual acuity with a sensitivity of 77% and a specificity of 75%. The results were similar for more than 5-letter changes and for 15-letter or more changes. Those with a 20% or more reduction in retinal thickness had a mean 11.0-letter improvement (95% confidence interval, 7.7 to 14.3) as compared with a -0.4-letter change (95% confidence interval, -4.1 to 3.3) in visual acuity for those without a 20% reduction (P < .01).

CONCLUSIONS

In addition to being above the level of measurement uncertainty, a 20% change in retinal thickness in patients with macular edema seems to be optimal for clinically important changes in visual acuity and may be considered as an outcome for clinical trials of treatments for uveitic macular edema.

摘要

目的

通过与视力变化的相关性,确定光相干断层扫描测量的葡萄膜炎性黄斑水肿患者视网膜厚度变化的临床有意义的阈值。

设计

横断面和纵向研究。

方法

101 例(128 只眼)黄斑水肿患者纳入多中心葡萄膜炎激素治疗(MUST)试验。在入组时和 6 个月随访时,使用时域光相干断层扫描仪测量中央子场视网膜厚度,使用对数(早期糖尿病视网膜病变治疗研究)视力表测量视力。如果视网膜厚度为 260 μm 或以上,则将患者归类为患有黄斑水肿。

结果

视网膜中心子场厚度变化 20%的阈值可以平衡预测视力变化超过 10 个字母的假阳性和假阴性的百分比,其敏感性为 77%,特异性为 75%。对于视力变化超过 5 个字母和 15 个字母或更多的情况,结果相似。与视网膜厚度减少 20%或更多的患者相比,视网膜厚度减少 20%的患者平均视力提高 11.0 个字母(95%置信区间,7.7 至 14.3),而视网膜厚度无减少 20%的患者视力变化为 -0.4 个字母(95%置信区间,-4.1 至 3.3)(P <.01)。

结论

除了高于测量不确定度水平外,黄斑水肿患者视网膜厚度变化 20%似乎与视力的临床重要变化最相关,可被视为葡萄膜炎性黄斑水肿治疗临床试验的结果。

相似文献

1
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.通过光学相干断层扫描评估葡萄膜炎性黄斑水肿的临床有意义的变化阈值。
Am J Ophthalmol. 2011 Dec;152(6):1044-1052.e5. doi: 10.1016/j.ajo.2011.05.028. Epub 2011 Sep 8.
2
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results.葡萄膜炎性黄斑水肿七年结局:多中心葡萄膜炎激素治疗试验及随访研究结果。
Ophthalmology. 2021 May;128(5):719-728. doi: 10.1016/j.ophtha.2020.08.035. Epub 2020 Sep 10.
3
Early treatment response of fluocinolone (retisert) implantation in patients with uveitic macular edema: an optical coherence tomography study.氟轻松(Retisert)植入治疗葡萄膜炎性黄斑水肿的早期疗效:光学相干断层扫描研究。
Retina. 2013 Apr;33(4):873-7. doi: 10.1097/IAE.0b013e31826d36dd.
4
Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.葡萄膜炎性黄斑水肿的治疗结果:多中心葡萄膜炎类固醇治疗试验2年结果
Ophthalmology. 2015 Nov;122(11):2351-9. doi: 10.1016/j.ophtha.2015.07.036. Epub 2015 Sep 7.
5
Subretinal fluid in uveitic macular edema: effect on vision and response to therapy.葡萄膜炎性黄斑水肿的视网膜下液:对视力的影响及对治疗的反应。
Am J Ophthalmol. 2013 Jan;155(1):143-9. doi: 10.1016/j.ajo.2012.06.028. Epub 2012 Sep 27.
6
Epiretinal membranes in uveitic macular edema: effect on vision and response to therapy.葡萄膜炎性黄斑水肿的视网膜前膜:对视力的影响及对治疗的反应。
Am J Ophthalmol. 2014 May;157(5):1048-55. doi: 10.1016/j.ajo.2014.01.020. Epub 2014 Jan 30.
7
SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion.SCORE研究报告1:视网膜静脉阻塞患者视网膜中央厚度与视力之间的基线关联
Ophthalmology. 2009 Mar;116(3):504-12. doi: 10.1016/j.ophtha.2008.10.017. Epub 2009 Jan 22.
8
Iluvien Implantation for Uveitis and Uveitic Macular Edema.Iluvien植入术治疗葡萄膜炎和葡萄膜炎性黄斑水肿。
Ocul Immunol Inflamm. 2018;26(2):315-316. doi: 10.1080/09273948.2016.1215472. Epub 2016 Oct 13.
9
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.黄斑水肿雷珠单抗与玻璃体内抗炎治疗试验:葡萄膜炎性黄斑水肿再治疗的24周结果
Ophthalmology. 2025 May;132(5):527-537. doi: 10.1016/j.ophtha.2024.11.021. Epub 2024 Nov 28.
10
Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.荧光素血管造影与光学相干断层扫描在葡萄膜炎性黄斑水肿诊断中的比较。
Ophthalmology. 2013 Sep;120(9):1852-9. doi: 10.1016/j.ophtha.2013.01.069. Epub 2013 May 21.

引用本文的文献

1
Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment.黄斑水肿雷珠单抗与玻璃体内抗炎治疗试验:葡萄膜炎性黄斑水肿再治疗的24周结果
Ophthalmology. 2025 May;132(5):527-537. doi: 10.1016/j.ophtha.2024.11.021. Epub 2024 Nov 28.
2
Retinal Function in Young Adults Following Topical Application of Levodopa to the Eye.年轻人眼部涂抹左旋多巴后的视网膜功能。
Transl Vis Sci Technol. 2024 Oct 1;13(10):12. doi: 10.1167/tvst.13.10.12.
3
Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results.

本文引用的文献

1
A proposed method of logarithmic transformation of optical coherence tomography data for use in clinical research.一种用于临床研究的光相干断层扫描数据对数转换的方法。
Ophthalmology. 2010 Aug;117(8):1512-6. doi: 10.1016/j.ophtha.2009.12.014. Epub 2010 Apr 3.
2
The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics.多中心葡萄膜炎皮质类固醇治疗试验:原理、设计和基线特征。
Am J Ophthalmol. 2010 Apr;149(4):550-561.e10. doi: 10.1016/j.ajo.2009.11.019. Epub 2010 Jan 25.
3
Efficacy of intravitreal bevacizumab (Avastin) for short-term treatment of diabetic macular edema.
眼内治疗葡萄膜炎性黄斑水肿-雷珠单抗与甲氨蝶呤与地塞米松植入物:MERIT 试验结果。
Ophthalmology. 2023 Sep;130(9):914-923. doi: 10.1016/j.ophtha.2023.04.011. Epub 2023 Jun 13.
4
Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review.抗VEGF治疗糖尿病性黄斑水肿中黄斑厚度与视力的关系:系统评价
J Vitreoretin Dis. 2022 Nov 18;7(1):57-64. doi: 10.1177/24741264221138722. eCollection 2023 Jan-Feb.
5
Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model.抗 Semaphorin 3A 中和抗体在雄性实验性视网膜静脉阻塞小鼠模型中的疗效。
Invest Ophthalmol Vis Sci. 2022 Jul 8;63(8):14. doi: 10.1167/iovs.63.8.14.
6
Long-term efficacy of dexamethasone intravitreal implant in the treatment of Vogt-Koyanagi-Harada disease relapsing posterior uveitis.地塞米松玻璃体内植入剂治疗 Vogt-小柳原田病复发后葡萄膜炎的长期疗效。
Indian J Ophthalmol. 2022 Jul;70(7):2465-2470. doi: 10.4103/ijo.IJO_260_22.
7
Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.与视网膜静脉阻塞相关的黄斑水肿的解剖学生物标志物。
Ophthalmol Retina. 2022 Dec;6(12):1206-1220. doi: 10.1016/j.oret.2022.06.016. Epub 2022 Jun 30.
8
The Conundrum of Clinical Trials for the Uveitides: Appropriate Outcome Measures for One Treatment Used in Several Diseases.葡萄膜炎临床试验的难题:一种治疗方法用于多种疾病的适当疗效指标。
Epidemiol Rev. 2022 Dec 21;44(1):2-16. doi: 10.1093/epirev/mxac001.
9
Safety and Efficacy of Suprachoroidal Injection of Triamcinolone in Treating Macular Edema Secondary to Noninfectious Uveitis.脉络膜上腔注射曲安奈德治疗非感染性葡萄膜炎继发性黄斑水肿的安全性和有效性
Cureus. 2021 Nov 30;13(11):e20038. doi: 10.7759/cureus.20038. eCollection 2021 Nov.
10
Optical Coherence Tomography Anatomic and Temporal Biomarkers in Uveitic Macular Edema.光学相干断层扫描在葡萄膜炎性黄斑水肿中的解剖和时间生物标志物。
Am J Ophthalmol. 2022 May;237:310-324. doi: 10.1016/j.ajo.2021.10.024. Epub 2021 Nov 3.
玻璃体内注射贝伐单抗(阿瓦斯汀)短期治疗糖尿病性黄斑水肿的疗效
J Med Invest. 2009 Aug;56(3-4):111-5. doi: 10.2152/jmi.56.111.
4
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results.使用醋酸氟轻松植入物治疗后葡萄膜炎:三年临床试验结果。
Arch Ophthalmol. 2008 Sep;126(9):1191-201. doi: 10.1001/archopht.126.9.1191.
5
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema.糖尿病性黄斑水肿光学相干断层扫描研究中的光学相干断层扫描测量与分析方法
Ophthalmology. 2008 Aug;115(8):1366-71, 1371.e1. doi: 10.1016/j.ophtha.2007.12.004.
6
Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography.葡萄膜炎性黄斑水肿:光学相干断层扫描模式与视力及荧光素血管造影之间的相关性
Br J Ophthalmol. 2008 Jul;92(7):922-7. doi: 10.1136/bjo.2007.136846.
7
A method of reporting macular edema after cataract surgery using optical coherence tomography.一种使用光学相干断层扫描报告白内障手术后黄斑水肿的方法。
Retina. 2008 Jun;28(6):870-6. doi: 10.1097/IAE.0b013e318169d04e.
8
Visual acuity as an outcome measure in clinical trials of retinal diseases.视力作为视网膜疾病临床试验中的一项结局指标。
Ophthalmology. 2007 Oct;114(10):1804-9. doi: 10.1016/j.ophtha.2007.06.047.
9
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.使用蔡司光学相干断层扫描技术测量糖尿病性黄斑水肿患者黄斑厚度和体积的可重复性
Ophthalmology. 2007 Aug;114(8):1520-5. doi: 10.1016/j.ophtha.2006.10.055. Epub 2007 Mar 13.
10
Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.使用光学相干断层扫描分析糖尿病患者白内障手术后的黄斑水肿。
Ophthalmology. 2007 May;114(5):881-9. doi: 10.1016/j.ophtha.2006.08.053. Epub 2007 Feb 1.